Carcinoembryonic antigen in gynecologic cancers. Immunohistochemical localization and serum levels.
The presence of carcinoembryonic antigen (CEA)-dependent fluorescence was observed in almost 89% of female genital tract cancers irrespective of their histologic type. Anti-CEA serum was free of antibody to normal cross-reacting antigen. The high percentage of positive fluorescence tests did not correlate with the preoperative serum CEA levels. Double immunodiffusion tests showed different content of CEA and normal cross-reacting antigen in individual specimens of genital tract cancers.
D002272:Carcinoembryonic Antigen / Q000032:analysis*; D003429:Cross Reactions; D005260:Female; D005455:Fluorescent Antibody Technique; D005833:Genital Neoplasms, Female / Q000276:immunology*; D006801:Humans; D005779:Immunodiffusion; D011863:Radioimmunoassay
D002272:Carcinoembryonic Antigen